Murray, D. L., Reich, L., & Adashi, E. Y. (1989). Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study. Fertility and Sterility, 51(1), 35-41. https://doi.org/10.1016/s0015-0282(16)60424-7
Murray DL, Reich L, Adashi EY. Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study. Fertil Steril. 1989;51(1):35-41. doi:10.1016/s0015-0282(16)60424-7
Murray, Denise L., et al. "Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study." Fertility and Sterility, vol. 51, no. 1, 1989, pp. 35-41.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
Clomiphene and progesterone showed no significant conception gap
This study looked back at the records of 65 infertility patients. All had luteal phase dysfunction (LPD), and biopsies showed it was fixed. Pregnancy rates over 12 months were not significantly different with clomiphene citrate or progesterone suppositories in this study. At 6 months, about 6 out of 10 clomiphene patients and 5 out of 10 progesterone patients were pregnant.
Key Findings
Sixty-five patients were studied: 35 treated with vaginal progesterone suppositories and 30 with oral clomiphene citrate. Four clomiphene patients were excluded because their biopsies stayed out of phase.
The cumulative conception rate by 1 year did not differ significantly between the groups (P = 0.7968): 81% with clomiphene citrate and 100% with progesterone suppositories.
At 6 months, 58% of clomiphene patients and 49% of progesterone patients were pregnant, compared with an estimated "normal" rate of 74%. At 12 months the estimated "normal" rate was 93%.
The progesterone curve differed from the theoretical normal curve (P < 0.01). The clomiphene curve could not be shown to differ from it (0.05 < P < 0.10, borderline).
Mean age was 31.67 years with clomiphene and 31.69 years with progesterone (P = 0.9004). Mean duration of infertility was 37.85 and 43.71 months (P = 0.2076).
Interpretation
This retrospective cohort study followed 65 patients. A biopsy confirmed that each patient's luteal phase problem was corrected. Then the study compared pregnancy rates between clomiphene citrate and vaginal progesterone suppositories. The authors call the two treatments similar once the biopsy shows correction. The authors note that a normal biopsy may not mean full recovery of function. The findings support larger studies of these cause-based treatments for luteal phase dysfunction.
RRM Context
Doctors found the luteal phase problem with a biopsy. They treated it, then confirmed correction before counting pregnancies. The approach fits core principles of restorative reproductive medicine: treat the root cause, and check the result before moving ahead. The authors compared their results with an earlier study showing lower pregnancy rates: 20.9% for clomiphene and 29.8% for progesterone.
Our editorial summary of this paper, not the article's abstract.
Abstract
Oral clomiphene citrate (CC) and vaginal progesterone suppositories (PS) are common treatment modalities in luteal phase dysfunction (LPD). Little is known regarding the relative efficacy of these agents. To study the use of CC and PS in the management of LPD, a retrospective cohort study of patients presenting with infertility was undertaken. Sixty-five patients in whom LPD was diagnosed and corrected, as judged by endometrial biopsies, were studied; 35 were treated with PS and 30 with CC. Using Student's t-tests and chi-square analyses, the two treatment groups were demographically comparable. Using life-table analysis, no one therapeutic approach proved superior. Clomiphene citrate and PS are comparable treatment modalities in the setting of LPD given correction of endometrial lag.